EnBio Holdings (TSE:6092) Scaled Net Operating Assets: 0.73 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6092 EnBio Holdings Inc TSE:6092
58 GF Score
Price 円728.00
GF Value 円799.37
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EnBio Holdings Scaled Net Operating Assets?

EnBio Holdings TSE:6092 +1.11% 58 Scaled Net Operating Assets is 0.73 as of Mar. 2026. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円799.37 (Fairly Valued). The stock has 4 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

EnBio Holdings's operating assets for the quarter that ended in Mar. 2026 was 円18,812 Mil. EnBio Holdings's operating liabilities for the quarter that ended in Mar. 2026 was 円2,871 Mil. EnBio Holdings's Total Assets for the quarter that ended in Dec. 2025 was 円21,749 Mil. Therefore, EnBio Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.73.


EnBio Holdings Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for EnBio Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EnBio Holdings Scaled Net Operating Assets Chart

EnBio Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.79 0.78 0.83 0.75

EnBio Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.77 0.74 0.70 0.73

TSE:6092 vs CTAS, CPRT, ULS: Scaled Net Operating Assets Comparison

For the Specialty Business Services subindustry, EnBio Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EnBio Holdings Scaled Net Operating Assets vs Business Services Industry

For the Business Services industry and Industrials sector, EnBio Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where EnBio Holdings's Scaled Net Operating Assets falls into.


TSE:6092
58GF Score
EnBio Holdings Inc TSE:6092
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EnBio Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

EnBio Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(18812-2871)/21195
=0.75

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=22848 - 4036
=18812

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13524 - 7766 - 2887
=2871

EnBio Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(18812-2871)/21749
=0.73

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=22848 - 4036
=18812

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13524 - 7766 - 2887
=2871

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.73 mean?
EnBio Holdings (TSE:6092) has a Scaled Net Operating Assets of 0.73 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on EnBio Holdings and its competitors.
Is EnBio Holdings' Scaled Net Operating Assets too high?
EnBio Holdings' current Scaled Net Operating Assets is 0.73. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Scaled Net Operating Assets compare to CTAS and CPRT?
EnBio Holdings' Scaled Net Operating Assets of 0.73 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Business Services company?
A good Scaled Net Operating Assets depends on the Business Services industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on EnBio Holdings and its competitors. EnBio Holdings's current Scaled Net Operating Assets is 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current Scaled Net Operating Assets is 0.73. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Scaled Net Operating Assets is 0.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EnBio Holdings (TSE:6092) Overvalued in 2026?

Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued. The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37. GuruFocus considers EnBio Holdings to be Fairly Valued.

Key valuation signals for TSE:6092:

  • Scaled Net Operating Assets: 0.73
  • GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EnBio Holdings Business Description

Address Tokyo Kandata cho 2-11 O-machi Takaku Building 3F, Chiyoda-ku, Tokyo, JPN
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score

Get the complete analysis for TSE:6092

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円728.00
Price
円799.37
GF Value